HEADER TRANSFERASE/TRANSFERASE INHIBITOR 14-OCT-22 8ESM TITLE HUMAN TRIACYLGLYCEROL SYNTHESIZING ENZYME DGAT1 IN COMPLEX WITH T863 TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIACYLGLYCEROL O-ACYLTRANSFERASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ACAT-RELATED GENE PRODUCT 1,ACYL-COA RETINOL O-FATTY- COMPND 5 ACYLTRANSFERASE,RETINOL O-FATTY-ACYLTRANSFERASE,DIGLYCERIDE COMPND 6 ACYLTRANSFERASE; COMPND 7 EC: 2.3.1.20,2.3.1.76; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DGAT1, AGRP1, DGAT; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS TRIGLYCERIDE BIOSYNTHESIS, LIPID STORAGE, LIPID METABOLISM, MEMBRANE KEYWDS 2 PROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR X.SUI,W.KUN,T.WALTHER,R.FARESE,M.LIAO REVDAT 1 07-JUN-23 8ESM 0 JRNL AUTH X.SUI,K.WANG,K.SONG,C.XU,J.SONG,C.W.LEE,M.LIAO, JRNL AUTH 2 R.V.FARESE JR.,T.C.WALTHER JRNL TITL MECHANISM OF ACTION FOR SMALL-MOLECULE INHIBITORS OF JRNL TITL 2 TRIACYLGLYCEROL SYNTHESIS. JRNL REF NAT COMMUN V. 14 3100 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 37248213 JRNL DOI 10.1038/S41467-023-38934-3 REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.200 REMARK 3 NUMBER OF PARTICLES : 36885 REMARK 3 CTF CORRECTION METHOD : NONE REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8ESM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1000269341. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CRYOEM DENSITY OF HUMAN REMARK 245 DIACYLGLYCEROL O- REMARK 245 ACYLTRANSFERASE 1 IN COMPLEX REMARK 245 WITH T863 INHIBITOR REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 5.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : CRYOEM DENSITY OF HUMAN REMARK 245 DIACYLGLYCEROL O-ACYLTRANSFERASE 1 IN COMPLEX WITH T863 INHIBITOR REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS; FEI TALOS REMARK 245 ARCTICA REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K); GATAN K2 REMARK 245 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1500.00; 1500.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 3500.00; 3500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD; BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4400.00; 3700.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM; FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN; FIELD REMARK 245 EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300; 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 ASP A 3 REMARK 465 ARG A 4 REMARK 465 GLY A 5 REMARK 465 SER A 6 REMARK 465 SER A 7 REMARK 465 ARG A 8 REMARK 465 ARG A 9 REMARK 465 ARG A 10 REMARK 465 ARG A 11 REMARK 465 THR A 12 REMARK 465 GLY A 13 REMARK 465 SER A 14 REMARK 465 ARG A 15 REMARK 465 PRO A 16 REMARK 465 SER A 17 REMARK 465 SER A 18 REMARK 465 HIS A 19 REMARK 465 GLY A 20 REMARK 465 GLY A 21 REMARK 465 GLY A 22 REMARK 465 GLY A 23 REMARK 465 PRO A 24 REMARK 465 ALA A 25 REMARK 465 ALA A 26 REMARK 465 ALA A 27 REMARK 465 GLU A 28 REMARK 465 GLU A 29 REMARK 465 GLU A 30 REMARK 465 VAL A 31 REMARK 465 ARG A 32 REMARK 465 ASP A 33 REMARK 465 ALA A 34 REMARK 465 ALA A 35 REMARK 465 ALA A 36 REMARK 465 GLY A 37 REMARK 465 PRO A 38 REMARK 465 ASP A 39 REMARK 465 VAL A 40 REMARK 465 GLY A 41 REMARK 465 ALA A 42 REMARK 465 ALA A 43 REMARK 465 GLY A 44 REMARK 465 ASP A 45 REMARK 465 ALA A 46 REMARK 465 PRO A 47 REMARK 465 ALA A 48 REMARK 465 PRO A 49 REMARK 465 ALA A 50 REMARK 465 PRO A 51 REMARK 465 ASN A 52 REMARK 465 LYS A 53 REMARK 465 ASP A 54 REMARK 465 GLY A 55 REMARK 465 ASP A 56 REMARK 465 ALA A 57 REMARK 465 GLY A 58 REMARK 465 VAL A 59 REMARK 465 GLY A 60 REMARK 465 SER A 61 REMARK 465 GLY A 62 REMARK 465 HIS A 63 REMARK 465 TRP A 64 REMARK 465 GLU A 65 REMARK 465 GLY A 229 REMARK 465 LYS A 230 REMARK 465 LYS A 231 REMARK 465 ALA A 232 REMARK 465 SER A 233 REMARK 465 SER A 234 REMARK 465 ALA A 235 REMARK 465 ALA A 236 REMARK 465 ALA A 237 REMARK 465 PRO A 238 REMARK 465 GLU A 482 REMARK 465 ALA A 483 REMARK 465 PRO A 484 REMARK 465 ALA A 485 REMARK 465 ALA A 486 REMARK 465 GLU A 487 REMARK 465 ALA A 488 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 ASP B 3 REMARK 465 ARG B 4 REMARK 465 GLY B 5 REMARK 465 SER B 6 REMARK 465 SER B 7 REMARK 465 ARG B 8 REMARK 465 ARG B 9 REMARK 465 ARG B 10 REMARK 465 ARG B 11 REMARK 465 THR B 12 REMARK 465 GLY B 13 REMARK 465 SER B 14 REMARK 465 ARG B 15 REMARK 465 PRO B 16 REMARK 465 SER B 17 REMARK 465 SER B 18 REMARK 465 HIS B 19 REMARK 465 GLY B 20 REMARK 465 GLY B 21 REMARK 465 GLY B 22 REMARK 465 GLY B 23 REMARK 465 PRO B 24 REMARK 465 ALA B 25 REMARK 465 ALA B 26 REMARK 465 ALA B 27 REMARK 465 GLU B 28 REMARK 465 GLU B 29 REMARK 465 GLU B 30 REMARK 465 VAL B 31 REMARK 465 ARG B 32 REMARK 465 ASP B 33 REMARK 465 ALA B 34 REMARK 465 ALA B 35 REMARK 465 ALA B 36 REMARK 465 GLY B 37 REMARK 465 PRO B 38 REMARK 465 ASP B 39 REMARK 465 VAL B 40 REMARK 465 GLY B 41 REMARK 465 ALA B 42 REMARK 465 ALA B 43 REMARK 465 GLY B 44 REMARK 465 ASP B 45 REMARK 465 ALA B 46 REMARK 465 PRO B 47 REMARK 465 ALA B 48 REMARK 465 PRO B 49 REMARK 465 ALA B 50 REMARK 465 PRO B 51 REMARK 465 ASN B 52 REMARK 465 LYS B 53 REMARK 465 ASP B 54 REMARK 465 GLY B 55 REMARK 465 ASP B 56 REMARK 465 ALA B 57 REMARK 465 GLY B 58 REMARK 465 VAL B 59 REMARK 465 GLY B 60 REMARK 465 SER B 61 REMARK 465 GLY B 62 REMARK 465 HIS B 63 REMARK 465 TRP B 64 REMARK 465 GLU B 65 REMARK 465 GLY B 229 REMARK 465 LYS B 230 REMARK 465 LYS B 231 REMARK 465 ALA B 232 REMARK 465 SER B 233 REMARK 465 SER B 234 REMARK 465 ALA B 235 REMARK 465 ALA B 236 REMARK 465 ALA B 237 REMARK 465 PRO B 238 REMARK 465 GLU B 482 REMARK 465 ALA B 483 REMARK 465 PRO B 484 REMARK 465 ALA B 485 REMARK 465 ALA B 486 REMARK 465 GLU B 487 REMARK 465 ALA B 488 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 284 OH TYR B 339 2.14 REMARK 500 OE2 GLU A 284 OH TYR A 339 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 70 -167.10 -79.36 REMARK 500 ASP A 79 26.65 -140.16 REMARK 500 PHE A 82 -64.13 -94.85 REMARK 500 TYR A 85 50.36 -90.47 REMARK 500 ARG A 86 47.59 -84.39 REMARK 500 PRO A 128 41.78 -82.02 REMARK 500 TRP A 131 71.83 -154.28 REMARK 500 THR A 160 156.58 -49.89 REMARK 500 ASN A 266 67.61 60.34 REMARK 500 ARG A 274 67.64 60.16 REMARK 500 GLN A 297 2.42 -69.73 REMARK 500 GLU A 368 45.88 -92.52 REMARK 500 SER A 399 76.25 60.32 REMARK 500 PHE A 426 45.63 -140.74 REMARK 500 PHE A 447 -61.20 -93.96 REMARK 500 ILE A 463 -70.40 -103.32 REMARK 500 ARG B 70 -167.12 -79.41 REMARK 500 ASP B 79 26.72 -140.19 REMARK 500 PHE B 82 -64.09 -94.90 REMARK 500 TYR B 85 50.41 -90.55 REMARK 500 ARG B 86 47.47 -84.29 REMARK 500 PRO B 128 41.77 -81.92 REMARK 500 TRP B 131 71.79 -154.37 REMARK 500 THR B 160 156.58 -49.92 REMARK 500 ASN B 266 67.69 60.38 REMARK 500 ARG B 274 67.65 60.19 REMARK 500 GLN B 297 2.45 -69.66 REMARK 500 GLU B 368 45.80 -92.49 REMARK 500 SER B 399 76.21 60.37 REMARK 500 PHE B 426 45.67 -140.79 REMARK 500 PHE B 447 -61.20 -93.90 REMARK 500 ILE B 463 -70.41 -103.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-28577 RELATED DB: EMDB REMARK 900 HUMAN TRIACYLGLYCEROL SYNTHESIZING ENZYME DGAT1 IN COMPLEX WITH REMARK 900 T863 INHIBITOR DBREF 8ESM A 1 488 UNP O75907 DGAT1_HUMAN 1 488 DBREF 8ESM B 1 488 UNP O75907 DGAT1_HUMAN 1 488 SEQRES 1 A 488 MET GLY ASP ARG GLY SER SER ARG ARG ARG ARG THR GLY SEQRES 2 A 488 SER ARG PRO SER SER HIS GLY GLY GLY GLY PRO ALA ALA SEQRES 3 A 488 ALA GLU GLU GLU VAL ARG ASP ALA ALA ALA GLY PRO ASP SEQRES 4 A 488 VAL GLY ALA ALA GLY ASP ALA PRO ALA PRO ALA PRO ASN SEQRES 5 A 488 LYS ASP GLY ASP ALA GLY VAL GLY SER GLY HIS TRP GLU SEQRES 6 A 488 LEU ARG CYS HIS ARG LEU GLN ASP SER LEU PHE SER SER SEQRES 7 A 488 ASP SER GLY PHE SER ASN TYR ARG GLY ILE LEU ASN TRP SEQRES 8 A 488 CYS VAL VAL MET LEU ILE LEU SER ASN ALA ARG LEU PHE SEQRES 9 A 488 LEU GLU ASN LEU ILE LYS TYR GLY ILE LEU VAL ASP PRO SEQRES 10 A 488 ILE GLN VAL VAL SER LEU PHE LEU LYS ASP PRO TYR SER SEQRES 11 A 488 TRP PRO ALA PRO CYS LEU VAL ILE ALA ALA ASN VAL PHE SEQRES 12 A 488 ALA VAL ALA ALA PHE GLN VAL GLU LYS ARG LEU ALA VAL SEQRES 13 A 488 GLY ALA LEU THR GLU GLN ALA GLY LEU LEU LEU HIS VAL SEQRES 14 A 488 ALA ASN LEU ALA THR ILE LEU CYS PHE PRO ALA ALA VAL SEQRES 15 A 488 VAL LEU LEU VAL GLU SER ILE THR PRO VAL GLY SER LEU SEQRES 16 A 488 LEU ALA LEU MET ALA HIS THR ILE LEU PHE LEU LYS LEU SEQRES 17 A 488 PHE SER TYR ARG ASP VAL ASN SER TRP CYS ARG ARG ALA SEQRES 18 A 488 ARG ALA LYS ALA ALA SER ALA GLY LYS LYS ALA SER SER SEQRES 19 A 488 ALA ALA ALA PRO HIS THR VAL SER TYR PRO ASP ASN LEU SEQRES 20 A 488 THR TYR ARG ASP LEU TYR TYR PHE LEU PHE ALA PRO THR SEQRES 21 A 488 LEU CYS TYR GLU LEU ASN PHE PRO ARG SER PRO ARG ILE SEQRES 22 A 488 ARG LYS ARG PHE LEU LEU ARG ARG ILE LEU GLU MET LEU SEQRES 23 A 488 PHE PHE THR GLN LEU GLN VAL GLY LEU ILE GLN GLN TRP SEQRES 24 A 488 MET VAL PRO THR ILE GLN ASN SER MET LYS PRO PHE LYS SEQRES 25 A 488 ASP MET ASP TYR SER ARG ILE ILE GLU ARG LEU LEU LYS SEQRES 26 A 488 LEU ALA VAL PRO ASN HIS LEU ILE TRP LEU ILE PHE PHE SEQRES 27 A 488 TYR TRP LEU PHE HIS SER CYS LEU ASN ALA VAL ALA GLU SEQRES 28 A 488 LEU MET GLN PHE GLY ASP ARG GLU PHE TYR ARG ASP TRP SEQRES 29 A 488 TRP ASN SER GLU SER VAL THR TYR PHE TRP GLN ASN TRP SEQRES 30 A 488 ASN ILE PRO VAL HIS LYS TRP CYS ILE ARG HIS PHE TYR SEQRES 31 A 488 LYS PRO MET LEU ARG ARG GLY SER SER LYS TRP MET ALA SEQRES 32 A 488 ARG THR GLY VAL PHE LEU ALA SER ALA PHE PHE HIS GLU SEQRES 33 A 488 TYR LEU VAL SER VAL PRO LEU ARG MET PHE ARG LEU TRP SEQRES 34 A 488 ALA PHE THR GLY MET MET ALA GLN ILE PRO LEU ALA TRP SEQRES 35 A 488 PHE VAL GLY ARG PHE PHE GLN GLY ASN TYR GLY ASN ALA SEQRES 36 A 488 ALA VAL TRP LEU SER LEU ILE ILE GLY GLN PRO ILE ALA SEQRES 37 A 488 VAL LEU MET TYR VAL HIS ASP TYR TYR VAL LEU ASN TYR SEQRES 38 A 488 GLU ALA PRO ALA ALA GLU ALA SEQRES 1 B 488 MET GLY ASP ARG GLY SER SER ARG ARG ARG ARG THR GLY SEQRES 2 B 488 SER ARG PRO SER SER HIS GLY GLY GLY GLY PRO ALA ALA SEQRES 3 B 488 ALA GLU GLU GLU VAL ARG ASP ALA ALA ALA GLY PRO ASP SEQRES 4 B 488 VAL GLY ALA ALA GLY ASP ALA PRO ALA PRO ALA PRO ASN SEQRES 5 B 488 LYS ASP GLY ASP ALA GLY VAL GLY SER GLY HIS TRP GLU SEQRES 6 B 488 LEU ARG CYS HIS ARG LEU GLN ASP SER LEU PHE SER SER SEQRES 7 B 488 ASP SER GLY PHE SER ASN TYR ARG GLY ILE LEU ASN TRP SEQRES 8 B 488 CYS VAL VAL MET LEU ILE LEU SER ASN ALA ARG LEU PHE SEQRES 9 B 488 LEU GLU ASN LEU ILE LYS TYR GLY ILE LEU VAL ASP PRO SEQRES 10 B 488 ILE GLN VAL VAL SER LEU PHE LEU LYS ASP PRO TYR SER SEQRES 11 B 488 TRP PRO ALA PRO CYS LEU VAL ILE ALA ALA ASN VAL PHE SEQRES 12 B 488 ALA VAL ALA ALA PHE GLN VAL GLU LYS ARG LEU ALA VAL SEQRES 13 B 488 GLY ALA LEU THR GLU GLN ALA GLY LEU LEU LEU HIS VAL SEQRES 14 B 488 ALA ASN LEU ALA THR ILE LEU CYS PHE PRO ALA ALA VAL SEQRES 15 B 488 VAL LEU LEU VAL GLU SER ILE THR PRO VAL GLY SER LEU SEQRES 16 B 488 LEU ALA LEU MET ALA HIS THR ILE LEU PHE LEU LYS LEU SEQRES 17 B 488 PHE SER TYR ARG ASP VAL ASN SER TRP CYS ARG ARG ALA SEQRES 18 B 488 ARG ALA LYS ALA ALA SER ALA GLY LYS LYS ALA SER SER SEQRES 19 B 488 ALA ALA ALA PRO HIS THR VAL SER TYR PRO ASP ASN LEU SEQRES 20 B 488 THR TYR ARG ASP LEU TYR TYR PHE LEU PHE ALA PRO THR SEQRES 21 B 488 LEU CYS TYR GLU LEU ASN PHE PRO ARG SER PRO ARG ILE SEQRES 22 B 488 ARG LYS ARG PHE LEU LEU ARG ARG ILE LEU GLU MET LEU SEQRES 23 B 488 PHE PHE THR GLN LEU GLN VAL GLY LEU ILE GLN GLN TRP SEQRES 24 B 488 MET VAL PRO THR ILE GLN ASN SER MET LYS PRO PHE LYS SEQRES 25 B 488 ASP MET ASP TYR SER ARG ILE ILE GLU ARG LEU LEU LYS SEQRES 26 B 488 LEU ALA VAL PRO ASN HIS LEU ILE TRP LEU ILE PHE PHE SEQRES 27 B 488 TYR TRP LEU PHE HIS SER CYS LEU ASN ALA VAL ALA GLU SEQRES 28 B 488 LEU MET GLN PHE GLY ASP ARG GLU PHE TYR ARG ASP TRP SEQRES 29 B 488 TRP ASN SER GLU SER VAL THR TYR PHE TRP GLN ASN TRP SEQRES 30 B 488 ASN ILE PRO VAL HIS LYS TRP CYS ILE ARG HIS PHE TYR SEQRES 31 B 488 LYS PRO MET LEU ARG ARG GLY SER SER LYS TRP MET ALA SEQRES 32 B 488 ARG THR GLY VAL PHE LEU ALA SER ALA PHE PHE HIS GLU SEQRES 33 B 488 TYR LEU VAL SER VAL PRO LEU ARG MET PHE ARG LEU TRP SEQRES 34 B 488 ALA PHE THR GLY MET MET ALA GLN ILE PRO LEU ALA TRP SEQRES 35 B 488 PHE VAL GLY ARG PHE PHE GLN GLY ASN TYR GLY ASN ALA SEQRES 36 B 488 ALA VAL TRP LEU SER LEU ILE ILE GLY GLN PRO ILE ALA SEQRES 37 B 488 VAL LEU MET TYR VAL HIS ASP TYR TYR VAL LEU ASN TYR SEQRES 38 B 488 GLU ALA PRO ALA ALA GLU ALA HET WS0 A 501 29 HET WS0 B 501 29 HETNAM WS0 {(1R,4R)-4-[4-(4-AMINO-7,7-DIMETHYL-7H-PYRIMIDO[4,5- HETNAM 2 WS0 B][1,4]OXAZIN-6-YL)PHENYL]CYCLOHEXYL}ACETIC ACID FORMUL 3 WS0 2(C22 H26 N4 O3) HELIX 1 AA1 GLY A 87 GLY A 112 1 26 HELIX 2 AA2 VAL A 115 ASP A 127 1 13 HELIX 3 AA3 TRP A 131 GLY A 157 1 27 HELIX 4 AA4 THR A 160 LEU A 185 1 26 HELIX 5 AA5 THR A 190 ALA A 226 1 37 HELIX 6 AA6 TYR A 243 LEU A 247 5 5 HELIX 7 AA7 THR A 248 LEU A 256 1 9 HELIX 8 AA8 ARG A 274 MET A 300 1 27 HELIX 9 AA9 MET A 300 GLN A 305 1 6 HELIX 10 AB1 ASP A 315 HIS A 343 1 29 HELIX 11 AB2 SER A 344 MET A 353 1 10 HELIX 12 AB3 SER A 369 TRP A 377 1 9 HELIX 13 AB4 ASN A 378 TYR A 390 1 13 HELIX 14 AB5 TYR A 390 ARG A 396 1 7 HELIX 15 AB6 SER A 399 SER A 420 1 22 HELIX 16 AB7 VAL A 421 ARG A 424 5 4 HELIX 17 AB8 TRP A 429 PHE A 447 1 19 HELIX 18 AB9 GLN A 449 ILE A 463 1 15 HELIX 19 AC1 GLN A 465 VAL A 478 1 14 HELIX 20 AC2 GLY B 87 GLY B 112 1 26 HELIX 21 AC3 VAL B 115 ASP B 127 1 13 HELIX 22 AC4 TRP B 131 GLY B 157 1 27 HELIX 23 AC5 THR B 160 LEU B 185 1 26 HELIX 24 AC6 THR B 190 ALA B 226 1 37 HELIX 25 AC7 TYR B 243 LEU B 247 5 5 HELIX 26 AC8 THR B 248 LEU B 256 1 9 HELIX 27 AC9 ARG B 274 MET B 300 1 27 HELIX 28 AD1 MET B 300 GLN B 305 1 6 HELIX 29 AD2 ASP B 315 HIS B 343 1 29 HELIX 30 AD3 SER B 344 MET B 353 1 10 HELIX 31 AD4 SER B 369 TRP B 377 1 9 HELIX 32 AD5 ASN B 378 TYR B 390 1 13 HELIX 33 AD6 TYR B 390 ARG B 396 1 7 HELIX 34 AD7 SER B 399 SER B 420 1 22 HELIX 35 AD8 VAL B 421 ARG B 424 5 4 HELIX 36 AD9 TRP B 429 PHE B 447 1 19 HELIX 37 AE1 GLN B 449 ILE B 463 1 15 HELIX 38 AE2 GLN B 465 VAL B 478 1 14 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000